<DOC>
	<DOCNO>NCT00135954</DOCNO>
	<brief_summary>Patients idiopathic membranous nephropathy risk renal failure identify early stage measure urinary low molecular weight protein urinary immunoglobulin G ( IgG ) . This study evaluate possible benefit early start immunosuppressive therapy high-risk patient .</brief_summary>
	<brief_title>Treatment Patients With Idiopathic Membranous Nephropathy</brief_title>
	<detailed_description>Inclusion Criteria : - patient idiopathic membranous nephropathy - nephrotic syndrome - normal renal function ( serum creatinine [ Screat ] &lt; 1.5 mg/dl ) - elevate urinary beta2-microglobulin IgG Immunosuppressive therapy consisting : - cyclophosphamide 1.5 mg/kg/day 12 month - prednisone orally , 0.5 mg/kg alternate day 6 month - i.v . methylprednisolone 1000 mg day 1,2,3 , 60,61,62 , 120,121,122 Study Groups : - early : immediate start immunosuppressive therapy time patient identify high-risk - late : start therapy deterioration renal function ( increase Screat &gt; 25 % Screat &gt; 1.5 mg/dl ) Main Outcome Parameters : - serum creatinine - remission proteinuria - period nephrotic proteinuria - major side effect : hospitalisation , infection</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , Membranous</mesh_term>
	<mesh_term>Glomerulonephritis</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Idiopathic membranous nephropathy Serum creatinine &lt; 1.5 mg/dl Nephrotic syndrome Infection Instable angina Systemic disease Pregnancy Renal vein thrombosis Prior therapy immunosuppressant agent Liver dysfunction Use nonsteroidal antiinflammatory drug ( NSAIDs )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>membranous nephropathy</keyword>
	<keyword>cyclophosphamide</keyword>
	<keyword>prednisone</keyword>
</DOC>